逆勢操作？KG Mobility發表全新Musso皮卡，增列汽油動力鞏固市場
韓國車廠KG Mobility發表全新Musso皮卡，除既有的柴油引擎外，首度增加汽油動力選項，旨在滿足更多元的市場需求。分析其在電動化浪潮下的雙軌策略與市場展望。
在電動車浪潮席捲全球之際，韓國車廠KG Mobility選擇了一條不同的道路。該公司於12月26日宣布，將在韓國國內市場推出全新改款的「Musso」皮卡，此舉不僅擴大了產品陣容，更重要的是首度加入了汽油引擎選項，意在滿足更多元的市場需求。根據官方說法，新車預計下個月正式上市。
擴大動力佈局：汽油、柴油雙管齊下
根據韓聯社報導，這款代號為「Q300」的全新Musso車型，將加入現有的「Musso Sports」與「Musso Sports Khan」行列。與過去兩個型號僅提供柴油動力的作法大相逕庭，新款Musso將同時提供汽油與柴油兩種版本。此舉被視為KG Mobility強化品牌競爭力、爭取更廣泛客戶群的關鍵一步。
銷售穩健成長與電動化未來
KG Mobility旗下產品線以SUV和皮卡車款為主，市場表現相當穩健。今年1月至11月期間，公司總銷量達到100,876輛，較去年同期的98,737輛增長了2.2%。儘管燃油車型推陳出新，該公司並未忽略電動化趨勢，其產品組合中也包含了韓國首款純電皮卡「Musso EV」以及純電SUV「Torres EVX」，展現了兼顧當下與未來的雙軌策略。
This content is AI-generated based on source articles. While we strive for accuracy, errors may occur. We recommend verifying with the original source.
Related Articles
KG Mobility has unveiled an all-new Musso pickup truck, now available with both gasoline and diesel engines. This move strengthens its lineup and broadens consumer choice in the South Korean market.
Samsung SDI and KG Mobility have signed an MOU to jointly develop advanced EV battery packs using next-generation 46-series cylindrical cells, signaling a deeper integration trend in the auto industry.
As India races to become an AI hub with a rapid data center expansion, local communities are facing a severe water crisis. An analysis of the hidden environmental and social costs.
AstraZeneca's $100 million upfront payment to China's Jacobio Pharma for a novel drug signals a major shift. The deal shows China's evolution from a generics maker to a key source of pharma innovation.
KG Mobility has unveiled an all-new Musso pickup truck, now available with both gasoline and diesel engines. This move strengthens its lineup and broadens consumer choice in the South Korean market.
Samsung SDI and KG Mobility have signed an MOU to jointly develop advanced EV battery packs using next-generation 46-series cylindrical cells, signaling a deeper integration trend in the auto industry.
As India races to become an AI hub with a rapid data center expansion, local communities are facing a severe water crisis. An analysis of the hidden environmental and social costs.
AstraZeneca's $100 million upfront payment to China's Jacobio Pharma for a novel drug signals a major shift. The deal shows China's evolution from a generics maker to a key source of pharma innovation.